Bruker Introduces A Broad Range of New Life Science and Analytical High-Performance Systems and Innovative Solutions at Pittcon
March 03 2008 - 5:00AM
Business Wire
Bruker Corporation (NASDAQ: BRKR) today introduces numerous
innovative high-performance systems and breakthrough solutions for
life science and materials research, for molecular imaging
research, for homeland security and environmental monitoring, as
well as for applied and industrial analysis at Pittcon 2008.
Several new Bruker solutions are available for cutting-edge small
molecule analysis in the pharmaceutical and biotech industries, as
well as in academic and clinical research: the unique new Complete
Molecular Confidence� solution for small molecule analysis combines
unambiguous on-the-fly SmartFormula� 3D molecular formula
determination by our new ESI-Qq-TOF mass spectrometer with
automated structure verification by NMR. Similarly exciting, drug
and metabolite tissue imaging at therapeutic dosing levels is now
enabled by a novel high-performance MALDI-FTMS imaging platform.
Moreover, the new FlashFormula� NALDI-TOF solution allows very
rapid, high-throughput small molecule detection and identification
without time-consuming LC separations. Finally, the breakthrough
X2S Crystal-to-Structure� small molecule X-ray system for the first
time allows chemists without crystallography training to obtain
routine small molecule 3D structures under full automation. Other
major Bruker product introductions further enhance proteomics
research: the new ETD II module for high-capacity spherical ion
traps takes automatic PTM analysis to a new sensitivity level and
protein mass range. The novel MALDI-TDS top-down solutions on
high-end TOF/TOF systems facilitate drug development and quality
control of biologics and now typically allow 100% sequence
determination, C- and N-terminal assignments, and the determination
of PEGylation sites and other modifications in recombinant proteins
. In materials research and industrial analysis, a novel benchtop
TXRF (total reflection XRF) system for facile, low-cost ultra-trace
elemental analysis may replace AA and ICP for many applications.
The new G8 GALILEO� ONH Combustion Analyzer is a result of our
recent JUWE acquisition, and complements our new Q4 TASMAN�
spark-OES system, both for metals analysis. For environmental
monitoring and homeland security we offer several new FT-IR based
systems for stand-off chemical agent and toxic industrial chemical
detection, as well as a new, small and portable FT-IR system for
the identification of suspicious or unknown powders. Frank Laukien,
Ph.D., President and CEO of Bruker Corporation, commented: �Our new
product offerings and novel capabilities introduced at Pittcon 2008
will further enhance our life science and analytical systems
business by providing many unmatched and truly innovative solutions
to our customers. This year�s exceptionally powerful line-up of new
product introductions clearly demonstrates the spirit of innovation
as well as the strong technical and market synergies of the various
Bruker businesses, which have recently all been combined within
Bruker Corporation. For our customers, some of our new enabling
solutions arguably represent real breakthroughs: reliable,
on-the-fly, unambiguous molecular formula determination for small
molecules up to 1 kDalton in mass, automated push-button small
molecule structure determination by chemists, pharmaceutical drug
and metabolite tissue imaging at therapeutic dosing levels,
automated, robust and exquisitely sensitive PTM discovery in
proteomics, and easy and robust ultra-trace elemental analysis with
portable TXRF instead of cumbersome AA or ICP with labor-intensive
sample preparation. For these pioneering novel solutions there has
been an unmet need for many years and sometimes even decades. We
believe that these solutions and their associated high-performance
instruments bring �sample-to-answer� life-science and analytical
systems to the next level.� Separate detailed trade journal and
scientific press releases are available for all new Bruker products
introduced and exhibited at Pittcon 2008: Life Science Mass
Spectrometry: New apex-ultra� small molecule and drug imaging
MALDI-FTMS solution with smartbeam� laser technology for drug
development, biological and clinical research, permitting drug and
metabolite tissue imaging at therapeutic dosing levels,
Next-generation micrOTOF�-Q II with new performance standards in
fast, high resolution and accurate LC/MS/MS performance with the
revolutionary SmartFormula 3D method for automated unambiguous
molecular formula determination, Novel MALDI-TOF/TOF
biotherapeutics analysis solution MALDI-TDS� that allows top-down
sequencing, PEGylation site and N/C-terminal assignments in protein
drugs, ETD II module for the HCT-Ultra� high capacity ion traps for
ultra-sensitive analysis of PTMs, such as phosphorylations or
glycosylations, up to 12 kDa proteins, New FlashFormula�
nanotechnology-assisted NALDI-TOF solution for rapid,
high-throughput small molecule detection and identification without
LC separations; NMR and FT-IR Molecular Spectroscopy: new Complete
Molecular Confidence� solution for small molecule molecular formula
determination by SmartFormula 3D followed by NMR automated
structure verification, Avance� III NanoBay compact NMR
spectrometer for chemistry research and teaching, Expanded NMR
Metabolic Profiling Database for identification and quantification
of more than 500 metabolites in body fluids and metabolites of
drugs and food ingredients, VERTEX 70v FT-IR spectrometer for
research with vacuum operation, The new research-grade EM 27 and
the new ruggedized HAWK FR for homeland security first responders
are both open-path FT-IR spectrometers to observe air
contamination, emissions from smoke stacks, waste disposal,
accidents or terror threats. The new Mobile-IR is a compact,
portable FT-IR with laboratory grade performance to identify
hazardous substances for environmental, crime scene and security
applications, The MultiRAM is an automated FT-Raman for research
and routine analysis of organics and inorganics, such as
nano-materials and pharma raw materials and formulations. The new
Bruker Analytical Services offerings for the pharmaceutical,
biotech and petroleum industries now include advanced FT-NMR,
TD-NMR and FTIR; X-ray, Spark-OES and Combustion Analysis:
Revolutionary SMART X2S (Crystal-to-Structure), the world�s first
benchtop X-Ray crystallography system for fully automated 3D
structure determination by chemists, Novel, robust and easy-to-use
S2 PICOFOX benchtop TXRF System for trace elemental analysis in
lieu of AA/ICP in pharma, geological, mining, environmental and
food testing Novel D2 CRYSO�, a unique bench-top crystal
orientation ED-XRD analyzer for the determination of lattice
orientations in growing and processing single crystal materials,
New G8 GALILEO ONH provides fast and precise determination of
Carbon, Sulfur, Oxygen, Nitrogen and Hydrogen by combustion
analysis for steel plants and foundries, New Q4 TASMAN benchtop
CCD-based spark OES offers simple routine handling, optimal
analytical performance and cost effective operation with minimal
maintenance. ABOUT BRUKER (NASDAQ: BRKR) As of February 26, 2008,
the renamed Bruker Corporation has become the parent company of the
entire Bruker group of companies. After the closing of the
acquisition of the Bruker BioSpin Group, Bruker Corporation now
operates in two segments, the life science and analytical (LSA)
systems segment, and the international advanced superconductor
(IAS) segment. For more information, please visit
www.bruker-biosciences.com.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024